Griffith's Institute for Glycomics has partnered with China Grand Pharma’s new Australian company Grand Medical Ltd to develop a drug to treat millions of people with respiratory illnesses.
A new experimental drug to treat sepsis has now entered the next stage of clinical trials in patients in Australia...
The Institute for Glycomics has been awarded two National Health and Medical Research Council Investigator Grants.
Director and Head of Research for the Institute for Glycomics Professor Mark von Itzstein AO has been honoured with the Gold Coast Citizen of the Year award.
Professor John Rasko is a globally pre-eminent physician-scientist whose work on regenerative medicine and biotechnology is fundamentally changing our understanding...
